NCT05949658View on ClinicalTrials.gov

Rapalog Pharmacology (RAP PAC) Study

PHASE1RecruitingINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

May 15, 2024

Primary Completion Date

March 31, 2027

Study Completion Date

December 31, 2028

Conditions
Aging
Interventions
DRUG

Sirolimus

5mg, 10mg, or 15mg once weekly sirolimus

DRUG

Everolimus

5mg, 10mg, or 15mg once weekly everolimus

Trial Locations (1)

53705

RECRUITING

University of Wisconsin, Madison

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute on Aging (NIA)

NIH

lead

University of Wisconsin, Madison

OTHER